Q3 FY2025 Earnings
Financial report interval: 2024.12.31 - 2025.03.31
Overview: MEI Pharma(MEIP) the EBIT is -1.774 M (+81.95%);the EPS is -0.386 (+71.81%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B81.95%
----
----
EPS
-0.386271.81%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf